MDS research criteria for prodromal Parkinson's disease

@article{Berg2015MDSRC,
  title={MDS research criteria for prodromal Parkinson's disease},
  author={D. Berg and R. Postuma and C. Adler and B. Bloem and P. Chan and B. Dubois and T. Gasser and C. Goetz and G. Halliday and L. Joseph and A. Lang and I. Liepelt-Scarfone and I. Litvan and K. Marek and J. Obeso and W. Oertel and C. Olanow and W. Poewe and M. Stern and G. Deuschl},
  journal={Movement Disorders},
  year={2015},
  volume={30}
}
This article describes research criteria and probability methodology for the diagnosis of prodromal PD. Prodromal disease refers to the stage wherein early symptoms or signs of PD neurodegeneration are present, but classic clinical diagnosis based on fully evolved motor parkinsonism is not yet possible. Given the lack of clear neuroprotective/disease‐modifying therapy for prodromal PD, these criteria were developed for research purposes only. The criteria are based upon the likelihood of… Expand
Update of the MDS research criteria for prodromal Parkinson's disease
TLDR
Diabetes, global cognitive deficit, physical inactivity, and low plasma urate levels in men enter the criteria as new markers, and several promising candidate markers may improve the diagnostic accuracy of prodromal PD in the future. Expand
The New Diagnostic Criteria for Parkinson's Disease.
TLDR
This chapter summarizes the advances in diagnosis of Parkinson's disease that were encapsulated in new International Parkinson Disease and Movement Disorders Society diagnostic criteria for PD, which includes a clinicogenetic subtype of PD and relies upon published studies of PD predictors to calculate the probability that any individual will develop PD. Expand
Biomarkers in Prodromal Parkinson Disease: a Qualitative Review
TLDR
Several objective biomarkers for prodromal PD show promise but require further study, including their application to and validation in prodromic cohorts followed longitudinally. Expand
Prevalence of Prodromal Parkinson's Disease as Defined by MDS Research Criteria among Elderly Patients Undergoing Colonoscopy.
TLDR
The findings suggest, that the prevalence of prodromal PD in patients undergoing diagnostic colonoscopies may be higher compared to the general elderly population, although this should be confirmed in further studies including also matched controls not undergoing colonoscopy. Expand
Diagnosing multiple system atrophy at the prodromal stage
TLDR
Building on similar approaches as for PD and DLB, features on history-taking, clinical examination, and ancillary clinical testing that can predict the likelihood of an individual developing MSA are identified, while also distinguishing it from PD andDLB. Expand
MDS clinical diagnostic criteria for Parkinson's disease
  • R. Postuma, D. Berg, +15 authors G. Deuschl
  • Psychology, Medicine
  • Movement disorders : official journal of the Movement Disorder Society
  • 2015
TLDR
The Movement Disorder Society PD Criteria retain motor parkinsonism as the core feature of the disease, defined as bradykinesia plus rest tremor or rigidity, and two levels of certainty are delineated: clinically established PD and probable PD. Expand
Diagnostic Criteria for Parkinson’s Disease: From James Parkinson to the Concept of Prodromal Disease
TLDR
This paper critically re-appraise the main diagnostic criteria proposed for PD, with particular attention to the recently published criteria by the International Parkinson and Movement Disorder Society (MDS) task force, underlying their novelty and focusing on the diagnostic issues still open. Expand
The Concept of Prodromal Parkinson’s Disease
TLDR
A key challenge in PD research is to identify and validate markers for the preclinical and prodromal stages of the illness, and several nonmotor symptoms have been associated with an increased risk to develop PD in otherwise healthy individuals. Expand
Prodromal and Early Parkinson ’ s Disease Diagnosis
Since its initial description in 1817,1 the diagnosis of Parkinson’s disease (PD) has focused on motor impairment. Currently accepted diagnostic criteria2,3 require the presence of bradykinesia andExpand
Prodromal PD: A new nosological entity.
TLDR
Individuals with RBD are a promising cohort for future clinical trials to detect and treat PD in its prodromal phase, and new markers, especially those derived from tissue biopsies, quantitative motor assessment and imaging, appear very promising. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 73 REFERENCES
Prodromal symptoms and early detection of Parkinson's disease in general practice: a nested case-control study.
TLDR
GPs should be alert when patients present with multiple prodromal symptoms in a two-year period, especially considering the benefits of early intervention, and the future possibilities for disease-modifying therapy. Expand
MDS clinical diagnostic criteria for Parkinson's disease
  • R. Postuma, D. Berg, +15 authors G. Deuschl
  • Psychology, Medicine
  • Movement disorders : official journal of the Movement Disorder Society
  • 2015
TLDR
The Movement Disorder Society PD Criteria retain motor parkinsonism as the core feature of the disease, defined as bradykinesia plus rest tremor or rigidity, and two levels of certainty are delineated: clinically established PD and probable PD. Expand
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.
TLDR
Using direct assessment of motor examination before parkinsonism in a REM sleep behaviour disorder, a prodromal interval of ∼4.5 years is estimated on the Unified Parkinson's Disease Rating Scale; other quantitative markers may detect parkinsonistan earlier. Expand
Defining at‐risk populations for Parkinson's disease: Lessons from ongoing studies
TLDR
The issues related to defining at‐risk populations forPD are discussed and findings of current population‐based cohorts that have reported potential biomarkers for PD are reviewed, such as the Honolulu‐Asia Aging Study (HAAS) and the PRIPS (Prospective Validation of Risk factors for the development of Parkinson Syndromes) study. Expand
Prediagnostic presentations of Parkinson's disease in primary care: a case-control study
TLDR
These data can be incorporated into ongoing efforts to identify individuals at the earliest stages of the disease for inclusion in future trials and to help understand progression in the earliest phase of Parkinson's disease. Expand
Toward a redefinition of Parkinson's disease
TLDR
With effective dopamine replacement therapy and increased patient longevity, it is time to redefine Parkinson’s disease to more accurately reflect the current state of knowledge, and the definition of early PD now need to change. Expand
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
TLDR
The risk of developing neurodegenerative disease in idiopathic REM sleep behavior disorder is substantial, with the majority of patients developing Parkinson disease and Lewy body dementia. Expand
Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study
TLDR
The results show that in first degree relatives of PD patients worse performance on each of three olfactory processing tasks was associated with an increased risk of developing PD within 5 years, whereas performance on selected tests of executive dysfunction was not associated with a increased riskof developing PD. Expand
Parkinson risk in idiopathic REM sleep behavior disorder
TLDR
Using stratification with simply assessed markers, it is now not only possible, but practical to include patients with RBD in neuroprotective trials against Parkinson disease, multiple system atrophy, and dementia with Lewy bodies. Expand
Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease
  • D. Berg, R. Postuma, +15 authors G. Deuschl
  • Psychology, Medicine
  • Movement disorders : official journal of the Movement Disorder Society
  • 2014
TLDR
A task force to consider a redefinition of Parkinson's disease identified several critical issues that challenge current PD definitions, and there is a need to create new MDS diagnostic criteria that take these changes in disease definition into consideration. Expand
...
1
2
3
4
5
...